Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17113829rdf:typepubmed:Citationlld:pubmed
pubmed-article:17113829lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:17113829lifeskim:mentionsumls-concept:C0030809lld:lifeskim
pubmed-article:17113829lifeskim:mentionsumls-concept:C0113216lld:lifeskim
pubmed-article:17113829lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:17113829lifeskim:mentionsumls-concept:C0019765lld:lifeskim
pubmed-article:17113829lifeskim:mentionsumls-concept:C1510996lld:lifeskim
pubmed-article:17113829lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:17113829pubmed:issue3lld:pubmed
pubmed-article:17113829pubmed:dateCreated2007-2-13lld:pubmed
pubmed-article:17113829pubmed:abstractTextIn the present study, we developed a HLA class II tetramer-based detection system utilizing DRB1*0402 tetramers loaded with recently identified immunodominant peptides of desmoglein 3 (Dsg3), the major autoantigen of pemphigus vulgaris (PV). Initial experiments demonstrated staining of a Dsg3-reactive T cell hybridoma which was derived from HLA-DR0402-transgenic mice with loaded PE-labeled DRbeta1*0402 tetramers. However, staining of autoreactive T cell clones (TCC) derived from PV patients resulted only in positive staining by addition of exogenous peptides to the staining reactions. There was a dose-dependent specific binding of TCC to the tetramers with the agonistic Dsg3 peptide which was not altered by exogenous unrelated Dsg3 peptide. Noteworthy, the TCC did not stain with HLA-DR4 tetramers complexed with unrelated Dsg3 peptides. The findings of this study suggest that HLA class II tetramers may provide a highly specific approach to monitor ex vivo the T cellular autoimmune response against Dsg3 in patients with PV.lld:pubmed
pubmed-article:17113829pubmed:languageenglld:pubmed
pubmed-article:17113829pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17113829pubmed:citationSubsetIMlld:pubmed
pubmed-article:17113829pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17113829pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17113829pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17113829pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17113829pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17113829pubmed:statusMEDLINElld:pubmed
pubmed-article:17113829pubmed:monthMarlld:pubmed
pubmed-article:17113829pubmed:issn1521-6616lld:pubmed
pubmed-article:17113829pubmed:authorpubmed-author:KwokWilliam...lld:pubmed
pubmed-article:17113829pubmed:authorpubmed-author:SonderstrupGr...lld:pubmed
pubmed-article:17113829pubmed:authorpubmed-author:HertlMichaelMlld:pubmed
pubmed-article:17113829pubmed:authorpubmed-author:EmingRüdigerRlld:pubmed
pubmed-article:17113829pubmed:authorpubmed-author:VeldmanChrist...lld:pubmed
pubmed-article:17113829pubmed:authorpubmed-author:Wolff-FrankeS...lld:pubmed
pubmed-article:17113829pubmed:issnTypePrintlld:pubmed
pubmed-article:17113829pubmed:volume122lld:pubmed
pubmed-article:17113829pubmed:ownerNLMlld:pubmed
pubmed-article:17113829pubmed:authorsCompleteYlld:pubmed
pubmed-article:17113829pubmed:pagination330-7lld:pubmed
pubmed-article:17113829pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:meshHeadingpubmed-meshheading:17113829...lld:pubmed
pubmed-article:17113829pubmed:year2007lld:pubmed
pubmed-article:17113829pubmed:articleTitleDetection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.lld:pubmed
pubmed-article:17113829pubmed:affiliationDepartment of Dermatology and Allergology, University of Marburg, Deutschhausstrasse 9, D-35033 Marburg, Germany. veldman@med.uni-marburg.delld:pubmed
pubmed-article:17113829pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:3123entrezgene:pubmedpubmed-article:17113829lld:entrezgene
entrez-gene:1830entrezgene:pubmedpubmed-article:17113829lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17113829lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17113829lld:entrezgene
lhgdn:association:33159lhgdn:found_inpubmed-article:17113829lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17113829lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17113829lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17113829lld:pubmed